Hopp til hovedinnhold

Koronavaksiner

Sist revidert:
Sist revidert av:
  1. Folkehelseinstituttet. Vaksinasjonsveilderen. Koronavaksine. Sist oppdatert 09.10.2023. Siden lest 16.10.2023. www.fhi.no  
  2. Fell DB, Dhinsa T, Alton GD, et al. Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes. JAMA 2022. pmid:35323842 PubMed  
  3. Fell DB, Dimanlig-Cruz S, Regan AK, et al. Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study. BMJ 2022; 378: e071416. doi:10.1136/bmj-2022-071416 DOI  
  4. Watanabe A, Yasuhara J, Iwagami M, et al. Peripartum Outcomes Associated With COVID-19 Vaccination During Pregnancy A Systematic Review and Meta-analysis. JAMA Pediatr 2022. pmid:36190704 PubMed  
  5. Tartof SY, Slezak JM, Fischer H, et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. . Lancet 2021. pmid:34619098 PubMed  
  6. Barda N, Dagan N, Cohen C, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet 2021. pmid:34756184 PubMed  
  7. MMWR. First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021. www.cdc.gov  
  8. Pillay J, Gaudete L, Wingert A, et al. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review. BMJ 2022; 378: e069445. doi:10.1136/bmj-2021-069445 DOI  
  9. Diaz GA, Parsons GT, Gering SK, et al. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA 2021. pmid:34347001 PubMed  
  10. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020. MMWR 2020; 69: 1922-4. doi:10.15585/mmwr.mm6950e2 DOI  
  11. Thompson MG, Burgess JL, Naleway AL, et al. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers—eight US locations, December 2020-March 2021. MMWR Morb Mortal Wkly Rep 2021 Mar 29. https://www.cdc.gov/mmwr/volumes/70/wr/mm7013e3.htm.
  12. Statens legemiddelverk. Nyheter. Meldte bivirkninger etter koronavaksine pr. 14. januar 2021 og Bruk av mRNA-vaksiner hos eldre. Publisert 14.01.2021. Siden besøkt 18.01.2021 legemiddelverket.no  
  13. CDC COVID-19 Response Team and Food and Drug Administration Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine — United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep 2021. doi: 10.15585/mmwr.mm7004e1 DOI  
  14. Blumenthal KG, Robinson LB, Camargo CA, et al. Acute Allergic Reactions to mRNA COVID-19 Vaccines. JAMA 2021. doi:10.1001/jama.2021.3976 DOI  
  15. Alnæs M, Storaas T, Sørensen M, et al. Covid-19-vaksiner gir økt risiko for anafylaksi. Tidsskr Nor Legeforen 2021. doi:10.4045/tidsskr.21.0109 DOI  
  16. Blumenthal KG, Freeman EF, Saff RR, et al. Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2. N Engl J Med 2021. doi:10.1056/NEJMc2102131 DOI  
  17. Li X, Raventos B, Roel E, et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ 2022; 376: e068373. pmid:35296468 PubMed  
  18. Montgomery J, Ryan M, Engler R, et al. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiology 2021. pmid:34185045 PubMed  
  19. Statens legemiddelverk. Myokarditt etter koronavaksinasjon. Nytt om legemidler nr. 16, 2021. nhi.no  
  20. Karlstad Ø, Hovi P, Husby A, et al. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents. JAMA Cardiol 2022. pmid:35442390 PubMed  
  21. Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2020. PMID: 33378609 PubMed  
  22. Bernal JL, Andrews N, Gower C, et al. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England. medRxiv 2021. doi:10.1101/2021.03.01.21252652 DOI  
  23. Madhi SA, Baillie V, Cutland CL, et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med 2021. doi:10.1056/NEJMoa2102214 DOI  
  24. Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021. pmid:33835768 PubMed  
  25. Pottegård A, Lund LC, Karlstad Ø, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ 2021; 373: n1114. pmid:33952445 PubMed  
  26. European Medicines Agency (EMA). Vaxzevria: EMA advises against use in people with history of capillary leak syndrome. EMA News 11.06.2021 www.ema.europa.eu  
  27. Statens Legemiddelverk. Tredje koronarvaksine godkjent i Europa. Nyheter 29.02.2021 legemiddelverket.no  
  28. WHO. WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out. WHO News 15.02.2021. www.who.int  
  29. Voysey M, Clemens SUA, Madhi SA, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet 2021. pmid:33617777 PubMed  
  30. Statens legemiddelverk. Fakta om godkjente koronavaksiner. Covid-19 Vaccine Janssen. legemiddelverket.no  
  31. Stephenson KE, Le Gars M, Sadoff J, et al. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA 2021. doi:10.1001/jama.2021.3645 DOI  
  • Ingard Løge, spesialist allmennmedisin, redaktør NEL